Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Parkinson Disease

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44341   clinical trials with a EudraCT protocol, of which   7370   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    426 result(s) found for: Parkinson Disease. Displaying page 3 of 22.
    « Previous 1  2  3  4  5  6  7  8  9  Next» Last»»
    EudraCT Number: 2014-001014-25 Sponsor Protocol Number: FBB-DBS-2014 Start Date*: 2016-07-20
    Sponsor Name:Fundació Clínic per la Recerca Biomèdica
    Full Title: Brain Amyloid-Beta burden as per florbetaben (Neuraceq) pet and cognitive outcomes after deep brain stimulation in Parkinsin's disease
    Medical condition: Parkinson's Disease
    Disease: Version SOC Term Classification Code Term Level
    19.0 10029205 - Nervous system disorders 10061536 Parkinson's disease PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2009-017416-33 Sponsor Protocol Number: 001.001 Start Date*: 2010-01-18
    Sponsor Name:Clinical research lab for neurodegeneration, Dept. of Neurology, St. Josef-Hospital, Ruhr-University
    Full Title: Standardized clinical trial on the application of Levodopa (LD) / Carbidopa (CD) to patients with Parkinson disease vs LD / CD and Entacapon (EN) vs LD / CD and Tolcapon (TO) concerning the paramet...
    Medical condition: Male and female patients with Parkinson´s disease meeting UKPDS criteria
    Disease: Version SOC Term Classification Code Term Level
    12.1 10013113 Disease Parkinson's LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2007-002496-14 Sponsor Protocol Number: 2939121 Start Date*: 2007-11-05
    Sponsor Name:Orion Corporation Orion Pharma
    Full Title: Effects of single doses of Stalevo 200 and levodopa/carbidopa 200/50 mg on striatal 11C-raclopride binding potential in Parkinson’s disease patients with wearing-off symptoms. An open, randomised, ...
    Medical condition: Parkinson’s disease
    Disease: Version SOC Term Classification Code Term Level
    9.1 10061536 Parkinson's disease LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FI (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2005-004290-19 Sponsor Protocol Number: SP873 Start Date*: 2006-01-25
    Sponsor Name:Schwarz Biosciences GmbH
    Full Title: A double-blind, placebo-controlled, parallel group, proof of concept trial to assess the tolerabiltiy, safety and efficacy of rotigotine nasal spray for the acute treatment of 'off' symptoms in sub...
    Medical condition: advanced-stage, idiopathic Parkinson's disease
    Disease: Version SOC Term Classification Code Term Level
    8.1 10061536 LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) AT (Completed) GB (Completed) ES (Completed)
    Trial results: View results
    EudraCT Number: 2007-000307-15 Sponsor Protocol Number: OV-1003 Start Date*: 2007-04-24
    Sponsor Name:OVATION PHARMACEUTICALS INC
    Full Title: Safety and Efficacy of Melperone in the Treatment of Patients with Psychosis Associated with Parkinson's Disease.
    Medical condition: Psicosi associata al morbo di Parkinson
    Disease: Version SOC Term Classification Code Term Level
    9.1 10013113 Disease Parkinson's LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: View results
    EudraCT Number: 2014-005630-60 Sponsor Protocol Number: TOZ-CL05 Start Date*: 2015-10-29
    Sponsor Name:Biotie Therapies Inc.(a wholly owned subsidiary of Acorda Therapeutics Inc.)
    Full Title: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- Controlled Study with an Open-Label Phase to Determine the Efficacy and Safety of Tozadenant as Adjunctive Therapy in Levodopa-Treated Pat...
    Medical condition: Parkinson’s Disease
    Disease: Version SOC Term Classification Code Term Level
    20.0 10029205 - Nervous system disorders 10061536 Parkinson's disease PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) CZ (Completed) ES (Completed) AT (Prematurely Ended) IT (Completed)
    Trial results: View results
    EudraCT Number: 2009-011144-19 Sponsor Protocol Number: 12962A Start Date*: 2009-11-19
    Sponsor Name:LUNDBECK ITALIA
    Full Title: A randomised, double-blind, placebo-controlled study to evaluate if rasagiline can improve depressive symptoms and cognitive function in non-demented, idiopathic Parkinson s disease patients.
    Medical condition: Subjects will be recruited from the Movement Disorders Outpatient Clinics from academic and hospital institutions in Italy. Only subjects with a BDI-IA score > or = 15 at baseline will be enrolled....
    Disease: Version SOC Term Classification Code Term Level
    9.1 10013113 LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: View results
    EudraCT Number: 2011-000612-26 Sponsor Protocol Number: FINTOURPARK Start Date*: 2011-09-19
    Sponsor Name:AZIENDA OSPEDALIERO UNIVERSITARIA DI CAGLIARI
    Full Title: Open-label study on the use of Finasteride in prolonged treatment (4 years) of tics in Tourette's disease and Parkinson's disease in the pounding
    Medical condition: Syndrome Gilles de la Tourette's disease Parkinosn Pounding
    Disease: Version SOC Term Classification Code Term Level
    14.1 10029205 - Nervous system disorders 10013113 Disease Parkinson's LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2005-004314-33 Sponsor Protocol Number: E2007-E044-301 Start Date*: 2006-02-02
    Sponsor Name:Eisai Limited
    Full Title: A Multi-centre, Randomised, Double-blind, Placebo-controlled, Parallel Group Study of the Efficacy, Safety and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients with Motor Fluc...
    Medical condition: Levodopa treated Parkinson's disease patients with motor fluctuations
    Disease: Version SOC Term Classification Code Term Level
    8.1 10061536
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: BE (Completed) EE (Completed) GB (Completed) DE (Completed) AT (Completed) SE (Completed) HU (Completed) LT (Completed) CZ (Completed) ES (Completed) PT (Completed) IT (Completed)
    Trial results: View results
    EudraCT Number: 2008-002769-30 Sponsor Protocol Number: 28780 Start Date*: 2009-04-30
    Sponsor Name:MERCK SERONO SA
    Full Title: A randomised, double-blind, placebo-controlled, two-period, two-sequence-crossover interaction study to assess the effect of safinamide on levodopa pharmacokinetics in subjects with Parkinson�s dis...
    Medical condition: Parkinson Disease
    Disease: Version SOC Term Classification Code Term Level
    9.1 10013113 LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: View results
    EudraCT Number: 2007-003134-42 Sponsor Protocol Number: CELC200AUS15 Start Date*: 2008-06-19
    Sponsor Name:Novartis Pharma Services AG
    Full Title: A 12-Week, Multi-center, Randomized, Prospective, Open-Label, Blinded Rater, Crossover Study of the Effects of Immediate-Release Carbidopa/Levodopa Versus Stalevo® on Markers of Event-Related Poten...
    Medical condition: Idiopathic Parkinson’s disease and end-of-dose wearing off.
    Disease: Version SOC Term Classification Code Term Level
    9.1 10061536 Parkinson's disease LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2008-006278-13 Sponsor Protocol Number: NL24092.042.08 Start Date*: 2009-02-04
    Sponsor Name:UMCG
    Full Title: Motor function optimization in advanced Parkinson’s disease patients, combined with galantamine to prevent visual hallucinations.
    Medical condition: patients with advanced (>5 years) Parkinson's disease and visual hallucinations.
    Disease: Version SOC Term Classification Code Term Level
    9.1 10047570 Visual hallucinations LLT
    9.1 10013113 Disease Parkinson's LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2006-005861-21 Sponsor Protocol Number: NW-1015/018/III/2006 Start Date*: 2007-06-11
    Sponsor Name:NEWRON PHARMACEUTICALS
    Full Title: A PHASE III, DOUBLE-BLIND, PLACEBO-CONTROLLED, 12-MONTH EXTENSION STUDY TO INVESTIGATE THE LONG-TERM EFFICACY AND SAFETY OF A LOW (50 MG/DAY) AND HIGH (100 MG/DAY) DOSE OF SAFINAMIDE, AS ADD-ON TH...
    Medical condition: Patients with idiopathic Parkinson's disease with motor fluctuations
    Disease: Version SOC Term Classification Code Term Level
    14.1 10029205 - Nervous system disorders 10061536 Parkinson's disease PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: View results
    EudraCT Number: 2008-003581-26 Sponsor Protocol Number: DuoCOMT2008-05-27 Start Date*: 2008-07-18
    Sponsor Name:Dept of Neuroscience, Uppsala University
    Full Title: Pharmacokinetics of levodopa using duodenal levodopa/carbidopa infusion with and without oral COMT inhibitors
    Medical condition: Parkinson's disease (G20.9), advanced, patients presently on Duodopa treatment.
    Disease: Version SOC Term Classification Code Term Level
    9.1 10013113 Disease Parkinson's LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2007-004400-12 Sponsor Protocol Number: FIRHSCSP/07/14 Start Date*: 2007-12-27
    Sponsor Name:Institut de Recerca de l'Hospital de la santa Creu i Sant Pau
    Full Title: ENSAYO RANDOMIZADO A DOBLE CIEGO Y CONTROLADO CON PLACEBO DE RASAGILINA EN PACIENTES CON ENFERMEDAD DE PARKINSON Y SINTOMAS DE APATIA
    Medical condition: Apatía en la Enfermedad de Parkinson
    Disease: Version SOC Term Classification Code Term Level
    9.1 10061536 Parkinson's disease LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2007-004234-16 Sponsor Protocol Number: 248.633 Start Date*: 2007-10-29
    Sponsor Name:Boehringer Ingelheim bv
    Full Title: Long-term safety study of open-label pramipexole extended release (ER) in patients with early Parkinson’s disease (PD).
    Medical condition: Male or female patients with early idiopathic Parkinson´s disease (PD) with Modified Hoehn and Yahr stage I-III.
    Disease: Version SOC Term Classification Code Term Level
    9.1 10061536 Parkinson's disease LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Completed) FR (Completed) CZ (Completed) HU (Completed) FI (Completed) AT (Completed) SK (Completed)
    Trial results: View results
    EudraCT Number: 2004-001330-16 Sponsor Protocol Number: ACT5288 Start Date*: 2004-10-21
    Sponsor Name:Sanofi-Synthélabo Recherche
    Full Title: Estudio de Fase II, aleatorizado, multicéntrico, doble ciego y controlado con placebo, del efecto de SR57667B sobre la función dopaminérgica nigro-estriada, evaluado mediante imágenes PET 18F-Dopa ...
    Medical condition: PARKINSON
    Disease: Version SOC Term Classification Code Term Level
    10061536 PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2009-013004-31 Sponsor Protocol Number: RASA-ROPI Start Date*: 2009-11-02
    Sponsor Name:UNIVERSITA` DEGLI STUDI DI PARMA
    Full Title: Early combined prolonged release ropinirole and rasagiline therapy in newly diagnosed patients with Parkinsons disease. A prospective, randomized, parallel groups, long-term follow-up study inc...
    Medical condition: Patients with Parkinson`s diesease
    Disease: Version SOC Term Classification Code Term Level
    12.0 10061536 Parkinson's disease LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2005-004949-34 Sponsor Protocol Number: 248.595 Start Date*: 2006-04-18
    Sponsor Name:Boehringer Ingelheim Austria GmbH
    Full Title: A randomized, double-blind, placebo-controlled, parallel-group clinical trial to examine the efficacy and safety of early pramipexole treatment versus delayed pramipexole treatment in patients with...
    Medical condition: Parkinson's disease
    Disease: Version SOC Term Classification Code Term Level
    6.1 10061536 pref
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: AT (Completed) GB (Completed) SE (Completed) DE (Completed) ES (Completed) FI (Completed) IT (Completed)
    Trial results: View results
    EudraCT Number: 2005-001416-42 Sponsor Protocol Number: TVP-1012/500 Start Date*: 2005-09-15
    Sponsor Name:Teva Pharmaceuticals Industries LtD
    Full Title: A Multicenter, Double-Blind, Randomized Start, Placebo-Controlled, Parallel-Group Study to Assess Rasagiline as a Disease Modifying Therapy in Early Parkinson’s Disease Subjects
    Medical condition: Parkinson's Disease
    Disease: Version SOC Term Classification Code Term Level
    7.1 10061536 PT
    Population Age: Adults Gender: Male, Female
    Trial protocol: GB (Completed) HU (Completed) IT (Completed) ES (Completed) AT (Completed) PT (Completed) DE (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    « Previous 1  2  3  4  5  6  7  8  9  Next» Last»»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sun Jun 08 07:43:12 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA